News Release

<< Back
Printer Friendly Version View printer-friendly version
Zix Corporation Recognized on Dallas-Fort Worth Top 50 Fastest Growing Technology Companies List; Company Ranks Fifth in Revenue Growth over Five-Year Period

DALLAS--(BUSINESS WIRE)--Aug. 24, 2005--Zix Corporation (ZixCorp(R)), (Nasdaq:ZIXI), a global provider of secure e-messaging and e-prescribing applications and services, today announced it has been recognized for the second year as a DFW Titan Fast 50 winner by the Metroplex Technology Business Council (MTBC). The company ranked fifth on this year's Fast 50 five-year growth list.

The fifth annual DFW Titan Fast 50 award recognizes the fastest-growing technology companies in the Dallas-Fort Worth area. The five-year growth list is based on the percentage of revenue growth over a five-year period from 2000 to 2004.

Winners must own proprietary technology and devote a significant proportion of revenues to research and development of technology. Winners of the DFW Metroplex list will also be eligible for the statewide Fast 50, as well as the North America Technology Fast 500.

"We are proud to be recognized again by the MTBC for our outstanding financial growth and achievement," said Rick Spurr, chief executive officer for ZixCorp. "Through a combination of strong technology solutions, market development, and dedicated employees, we've built our portfolio and customer base to help us continue to grow and expand on our success."

The full list of the Fast 50 award winners will be announced in the Dallas Business Journal Aug. 26 issue. For more information about the award, visit

About Zix Corporation

Zix Corporation (ZixCorp(R)) provides easy-to-use-and-deploy e-communication services that protect, manage, and deliver sensitive information to enterprises and consumers in healthcare, finance, insurance, and government. ZixCorp's eSecure services enable policy-driven email encryption, content filtering, and send-to-anyone capability while its eHealth services improve patient care, reduce costs, and improve efficiency through e-prescribing and e-lab solutions. For more information, visit

Public Relations
Christa Osswald, 214-370-2175
Investor Relations
Peter Wilensky, 214-515-7357

SOURCE: Zix Corporation